Changes in the mumps vaccine coverage and incidence of mumps before and after the public subsidization program: A descriptive study using a population-based database in Japan

IF 3.8 3区医学 Q2 INFECTIOUS DISEASES

American journal of infection control Pub Date : 2025-01-01 DOI:10.1016/j.ajic.2024.09.011

So Sato MD , Sachiko Ono DDS, MPH, PhD , Yusuke Sasabuchi MD, MPH, PhD , Kohei Uemura PhD , Hideo Yasunaga MD, PhD

{"title":"Changes in the mumps vaccine coverage and incidence of mumps before and after the public subsidization program: A descriptive study using a population-based database in Japan","authors":"So Sato MD , Sachiko Ono DDS, MPH, PhD , Yusuke Sasabuchi MD, MPH, PhD , Kohei Uemura PhD , Hideo Yasunaga MD, PhD","doi":"10.1016/j.ajic.2024.09.011","DOIUrl":null,"url":null,"abstract":"<div><h3>Background</h3><div>Continuous mumps vaccine coverage is essential for eradicating mumps. However, due to safety concerns, Japan’s mumps vaccination program transitioned from routine to voluntary. To improve coverage, some municipalities introduced subsidization programs, but the effects on vaccination rates and mumps incidence remain unclear.</div></div><div><h3>Methods</h3><div>In April 2018, a city in Japan launched a subsidization program for the mumps vaccine for children aged 1–6 years. Using vaccination records and healthcare claims from July 2016 to December 2019, we analyzed changes in vaccination coverage and mumps incidence before and after the program’s initiation.</div></div><div><h3>Results</h3><div>At the program’s start, mumps vaccination coverage among eligible children was 3.3%, increasing by approximately 1.5% monthly to 38.4% after 21 months. Among 308,976 individuals, 145 mumps cases were identified: 92 cases (0.27 per 1,000 person-years) occurred before, and 53 (0.15 per 1,000 person-years) occurred after the program’s start.</div></div><div><h3>Conclusions</h3><div>Although the mumps vaccination coverage rate increased following the program’s initiation, it remained below the level required for eradication.</div></div>","PeriodicalId":7621,"journal":{"name":"American journal of infection control","volume":"53 1","pages":"Pages 82-86"},"PeriodicalIF":3.8000,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American journal of infection control","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0196655324007168","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}

引用次数: 0

Abstract

Background

Continuous mumps vaccine coverage is essential for eradicating mumps. However, due to safety concerns, Japan’s mumps vaccination program transitioned from routine to voluntary. To improve coverage, some municipalities introduced subsidization programs, but the effects on vaccination rates and mumps incidence remain unclear.

Methods

In April 2018, a city in Japan launched a subsidization program for the mumps vaccine for children aged 1–6 years. Using vaccination records and healthcare claims from July 2016 to December 2019, we analyzed changes in vaccination coverage and mumps incidence before and after the program’s initiation.

Results

At the program’s start, mumps vaccination coverage among eligible children was 3.3%, increasing by approximately 1.5% monthly to 38.4% after 21 months. Among 308,976 individuals, 145 mumps cases were identified: 92 cases (0.27 per 1,000 person-years) occurred before, and 53 (0.15 per 1,000 person-years) occurred after the program’s start.

Conclusions

Although the mumps vaccination coverage rate increased following the program’s initiation, it remained below the level required for eradication.

查看原文本刊更多论文

公共补贴计划前后腮腺炎疫苗覆盖率和腮腺炎发病率的变化：利用日本人口数据库进行的描述性研究。

背景有证据表明，持续接种流行性腮腺炎疫苗可以根除流行性腮腺炎感染。然而，出于安全考虑，日本的流行性腮腺炎疫苗接种计划从常规转为自愿。为了提高疫苗接种覆盖率，一些市镇开始独立提供流行性腮腺炎疫苗补贴计划。然而，在启动补贴计划前后，疫苗接种覆盖率和流行性腮腺炎发病率的变化仍是未知数。方法2018年4月，日本某市启动了针对1-6岁儿童的流行性腮腺炎疫苗补贴计划。本研究使用了该市在 2016 年 7 月至 2019 年 12 月期间获得的疫苗接种记录和医疗报销数据。结果在该计划启动时，符合条件的儿童腮腺炎疫苗接种覆盖率为 3.3%；该覆盖率每月增加约 1.5%，在计划启动 21 个月后达到 38.4%。在 308,976 人中发现了 145 例流行性腮腺炎病例；其中 92 例（每千人年 0.27 例）发生在补贴计划启动之前，53 例（每千人年 0.15 例）发生在补贴计划启动之后。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

American journal of infection control 医学-传染病学

CiteScore

7.40

自引率

4.10%

发文量

479

审稿时长

24 days

期刊介绍： AJIC covers key topics and issues in infection control and epidemiology. Infection control professionals, including physicians, nurses, and epidemiologists, rely on AJIC for peer-reviewed articles covering clinical topics as well as original research. As the official publication of the Association for Professionals in Infection Control and Epidemiology (APIC)